Compared to f‐Hb ≥ 10 μg/g the Cox model, if implemented in a population of 100,000 people having FITs, might reduce the number of referrals and tests by > 4700 with minimal change in the number of cancers that would be missed. The gene discussed is GSTM1; the disease is cancer.